Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 25576 | 230 | 54.1 | 90% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 14 | 37098 | ALZHEIMERS DISEASE//AMYLOID PRECURSOR PROTEIN//BETA AMYLOID |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CUERPO NEUROQUIM | Address | 3 | 60% | 1% | 3 |
| 2 | NEUROREGENERAT GRP | Address | 2 | 67% | 1% | 2 |
| 3 | TEAM ANIM OURCES | Address | 2 | 67% | 1% | 2 |
| 4 | APPSW | Author keyword | 1 | 50% | 1% | 2 |
| 5 | CLINICAL DEMENTIA | Author keyword | 1 | 100% | 1% | 2 |
| 6 | EXON MICROARRAYS | Author keyword | 1 | 50% | 1% | 2 |
| 7 | MENTAL IMPAIRMENTS NEUROL DISORDERS MIND | Address | 1 | 100% | 1% | 2 |
| 8 | BIOMARKER PROGRAM | Address | 1 | 27% | 1% | 3 |
| 9 | EVE TOPF NEURODEGENERAT DIS | Address | 1 | 20% | 2% | 4 |
| 10 | BLOOD MONONUCLEAR CELL | Author keyword | 1 | 33% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | APPSW | 1 | 50% | 1% | 2 | Search APPSW | Search APPSW |
| 2 | CLINICAL DEMENTIA | 1 | 100% | 1% | 2 | Search CLINICAL+DEMENTIA | Search CLINICAL+DEMENTIA |
| 3 | EXON MICROARRAYS | 1 | 50% | 1% | 2 | Search EXON+MICROARRAYS | Search EXON+MICROARRAYS |
| 4 | BLOOD MONONUCLEAR CELL | 1 | 33% | 1% | 2 | Search BLOOD+MONONUCLEAR+CELL | Search BLOOD+MONONUCLEAR+CELL |
| 5 | DOPAMINERGIC MARKERS | 1 | 33% | 1% | 2 | Search DOPAMINERGIC+MARKERS | Search DOPAMINERGIC+MARKERS |
| 6 | APOSKLESIS | 1 | 50% | 0% | 1 | Search APOSKLESIS | Search APOSKLESIS |
| 7 | BIOLOGICAL INSIGHT | 1 | 50% | 0% | 1 | Search BIOLOGICAL+INSIGHT | Search BIOLOGICAL+INSIGHT |
| 8 | CELLULAR REPLICATIVE SENESCENCE | 1 | 50% | 0% | 1 | Search CELLULAR+REPLICATIVE+SENESCENCE | Search CELLULAR+REPLICATIVE+SENESCENCE |
| 9 | CHROMOWAVE | 1 | 50% | 0% | 1 | Search CHROMOWAVE | Search CHROMOWAVE |
| 10 | COMPLEMENTARY DNA CDNA MICROARRAY ANALYSIS | 1 | 50% | 0% | 1 | Search COMPLEMENTARY+DNA+CDNA+MICROARRAY+ANALYSIS | Search COMPLEMENTARY+DNA+CDNA+MICROARRAY+ANALYSIS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LATERAL SUBSTANTIA NIGRA | 4 | 75% | 1% | 3 |
| 2 | NSE CONTROLLED APPSW | 2 | 67% | 1% | 2 |
| 3 | ALZHEIMERS DISEASE DEMENTIA | 1 | 40% | 1% | 2 |
| 4 | PERIPHERAL BIOMARKERS | 1 | 40% | 1% | 2 |
| 5 | BIOLOGICAL THEMES | 1 | 50% | 0% | 1 |
| 6 | GLIAL CELL NUMBERS | 1 | 50% | 0% | 1 |
| 7 | HLJ1 | 1 | 50% | 0% | 1 |
| 8 | GENOMIC CONVERGENCE | 1 | 29% | 1% | 2 |
| 9 | PSYCHOPHARMACOLOGICAL NEUROPROTECTION | 0 | 33% | 0% | 1 |
| 10 | TRANSCRIPTIONAL SIGNATURES | 0 | 33% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Gene expression profiling in human neurodegenerative disease | 2012 | 48 | 123 | 28% |
| Current status and future directions of gene expression profiling in Parkinson's disease | 2012 | 9 | 44 | 43% |
| The 9th Siena Meeting: from Genome to Proteome: Open Innovations | 2012 | 1 | 4 | 50% |
| Understanding the pathogenesis of Alzheimer's disease: will RNA-Seq realize the promise of transcriptomics? | 2011 | 14 | 91 | 18% |
| Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: Statistical reliability and functional correlation | 2005 | 61 | 69 | 12% |
| Transcriptome profiling in neurodegenerative disease | 2010 | 25 | 139 | 10% |
| Psychotropics regulate Skp1a, Aldh1a1, and Hspa8 transcription - Potential to delay Parkinson's disease | 2013 | 1 | 12 | 17% |
| Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits | 2012 | 6 | 129 | 11% |
| The application of microarray technology to neuropathology: Cutting edge tool with clinical diagnostics potential or too much information? | 2006 | 8 | 46 | 17% |
| Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease | 2010 | 26 | 126 | 8% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CUERPO NEUROQUIM | 3 | 60% | 1.3% | 3 |
| 2 | NEUROREGENERAT GRP | 2 | 67% | 0.9% | 2 |
| 3 | TEAM ANIM OURCES | 2 | 67% | 0.9% | 2 |
| 4 | MENTAL IMPAIRMENTS NEUROL DISORDERS MIND | 1 | 100% | 0.9% | 2 |
| 5 | BIOMARKER PROGRAM | 1 | 27% | 1.3% | 3 |
| 6 | EVE TOPF NEURODEGENERAT DIS | 1 | 20% | 1.7% | 4 |
| 7 | LIM 22 | 1 | 33% | 0.9% | 2 |
| 8 | NEUROPROTE GRP | 1 | 33% | 0.9% | 2 |
| 9 | PARKINSON FDN EXCELLENCE S | 1 | 21% | 1.3% | 3 |
| 10 | CTY HOSP RYHOV | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000195337 | BRAIN BANK//AGONAL STATE//BRAIN BANKS |
| 2 | 0.0000119503 | MERIEUX//BLOOD TRANSCRIPTOME//DUTCH NUTRIGENOM CONSORTIUM |
| 3 | 0.0000116810 | LRRK2//LEUCINE RICH REPEAT KINASE 2//PARK8 |
| 4 | 0.0000110767 | RNA AMPLIFICATION//LASER CAPTURE MICRODISSECTION//LASER MICRODISSECTION |
| 5 | 0.0000103550 | SORL1//TOMM40//PICALM |
| 6 | 0.0000095166 | PERIPHERAL CELLS//GERIATR MEDKFC//NORMAL HUMAN SKIN FIBROBLASTS |
| 7 | 0.0000086985 | ABAD//ERAB//STUDY NEURODEGENERAT DIS |
| 8 | 0.0000084475 | ALPHA 1 ANTICHYMOTRYPSIN//D10S1423//PSYCHIATGERONTOL UNIT |
| 9 | 0.0000083029 | VOXELATION//GPR88//GENE EXPRESSION TOMOGRAPHY |
| 10 | 0.0000081868 | ALPHA SYNUCLEIN//SYNUCLEIN//BETA SYNUCLEIN |